The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drug Abuse Testing-Global Market Insights and Sales Trends 2024
Synopsis
Drugs of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. Testing detects substances not normally found in the body, with the exception of some hormones and steroids measured as part of sports testing.
The global Drug Abuse Testing market size is expected to reach US$ 28250 million by 2029, growing at a CAGR of 6.6% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Abuse Testing in various end use industries. The expanding demands from the Schools and Educational Institutes, Hospitals and Healthcare Units and Government and Private Departments,, are propelling Drug Abuse Testing market. Random Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reasonable Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Abuse Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Abuse Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Abuse Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Abuse Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Abuse Testing covered in this report include Biomedical Diagnostics, BioMerieux, Abbott, Bio-Rad, Dako, DiaSorin, Eiken, Fujirebio and Beckman Coulter, etc.
The global Drug Abuse Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biomedical Diagnostics
BioMerieux
Abbott
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Beckman Coulter
Global Drug Abuse Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Abuse Testing market, Segment by Type:
Random Testing
Reasonable Testing
Post accident Testing
Follow-up Testing
Global Drug Abuse Testing market, by Application
Schools and Educational Institutes
Hospitals and Healthcare Units
Government and Private Departments
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Abuse Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Drugs of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. Testing detects substances not normally found in the body, with the exception of some hormones and steroids measured as part of sports testing.
The global Drug Abuse Testing market size is expected to reach US$ 28250 million by 2029, growing at a CAGR of 6.6% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Abuse Testing in various end use industries. The expanding demands from the Schools and Educational Institutes, Hospitals and Healthcare Units and Government and Private Departments,, are propelling Drug Abuse Testing market. Random Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reasonable Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Abuse Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Abuse Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Abuse Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Abuse Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Abuse Testing covered in this report include Biomedical Diagnostics, BioMerieux, Abbott, Bio-Rad, Dako, DiaSorin, Eiken, Fujirebio and Beckman Coulter, etc.
The global Drug Abuse Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biomedical Diagnostics
BioMerieux
Abbott
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Beckman Coulter
Global Drug Abuse Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Abuse Testing market, Segment by Type:
Random Testing
Reasonable Testing
Post accident Testing
Follow-up Testing
Global Drug Abuse Testing market, by Application
Schools and Educational Institutes
Hospitals and Healthcare Units
Government and Private Departments
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Abuse Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Drug Abuse Testing
1.1 Drug Abuse Testing Market Overview
1.1.1 Drug Abuse Testing Product Scope
1.1.2 Drug Abuse Testing Market Status and Outlook
1.2 Global Drug Abuse Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug Abuse Testing Market Size by Region (2018-2029)
1.4 Global Drug Abuse Testing Historic Market Size by Region (2018-2023)
1.5 Global Drug Abuse Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug Abuse Testing Market Size (2018-2029)
1.6.1 North America Drug Abuse Testing Market Size (2018-2029)
1.6.2 Europe Drug Abuse Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Drug Abuse Testing Market Size (2018-2029)
1.6.4 Latin America Drug Abuse Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Drug Abuse Testing Market Size (2018-2029)
2 Drug Abuse Testing Market by Type
2.1 Introduction
2.1.1 Random Testing
2.1.2 Reasonable Testing
2.1.3 Post accident Testing
2.1.4 Follow-up Testing
2.2 Global Drug Abuse Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug Abuse Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Drug Abuse Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug Abuse Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug Abuse Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug Abuse Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug Abuse Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug Abuse Testing Revenue Breakdown by Type (2018-2029)
3 Drug Abuse Testing Market Overview by Application
3.1 Introduction
3.1.1 Schools and Educational Institutes
3.1.2 Hospitals and Healthcare Units
3.1.3 Government and Private Departments
3.2 Global Drug Abuse Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug Abuse Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Drug Abuse Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug Abuse Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug Abuse Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug Abuse Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug Abuse Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug Abuse Testing Revenue Breakdown by Application (2018-2029)
4 Drug Abuse Testing Competition Analysis by Players
4.1 Global Drug Abuse Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Abuse Testing as of 2022)
4.3 Date of Key Players Enter into Drug Abuse Testing Market
4.4 Global Top Players Drug Abuse Testing Headquarters and Area Served
4.5 Key Players Drug Abuse Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Abuse Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biomedical Diagnostics
5.1.1 Biomedical Diagnostics Profile
5.1.2 Biomedical Diagnostics Main Business
5.1.3 Biomedical Diagnostics Drug Abuse Testing Products, Services and Solutions
5.1.4 Biomedical Diagnostics Drug Abuse Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Biomedical Diagnostics Recent Developments
5.2 BioMerieux
5.2.1 BioMerieux Profile
5.2.2 BioMerieux Main Business
5.2.3 BioMerieux Drug Abuse Testing Products, Services and Solutions
5.2.4 BioMerieux Drug Abuse Testing Revenue (US$ Million) & (2018-2023)
5.2.5 BioMerieux Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Drug Abuse Testing Products, Services and Solutions
5.3.4 Abbott Drug Abuse Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Recent Developments
5.4 Bio-Rad
5.4.1 Bio-Rad Profile
5.4.2 Bio-Rad Main Business
5.4.3 Bio-Rad Drug Abuse Testing Products, Services and Solutions
5.4.4 Bio-Rad Drug Abuse Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Recent Developments
5.5 Dako
5.5.1 Dako Profile
5.5.2 Dako Main Business
5.5.3 Dako Drug Abuse Testing Products, Services and Solutions
5.5.4 Dako Drug Abuse Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Dako Recent Developments
5.6 DiaSorin
5.6.1 DiaSorin Profile
5.6.2 DiaSorin Main Business
5.6.3 DiaSorin Drug Abuse Testing Products, Services and Solutions
5.6.4 DiaSorin Drug Abuse Testing Revenue (US$ Million) & (2018-2023)
5.6.5 DiaSorin Recent Developments
5.7 Eiken
5.7.1 Eiken Profile
5.7.2 Eiken Main Business
5.7.3 Eiken Drug Abuse Testing Products, Services and Solutions
5.7.4 Eiken Drug Abuse Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Eiken Recent Developments
5.8 Fujirebio
5.8.1 Fujirebio Profile
5.8.2 Fujirebio Main Business
5.8.3 Fujirebio Drug Abuse Testing Products, Services and Solutions
5.8.4 Fujirebio Drug Abuse Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Fujirebio Recent Developments
5.9 Beckman Coulter
5.9.1 Beckman Coulter Profile
5.9.2 Beckman Coulter Main Business
5.9.3 Beckman Coulter Drug Abuse Testing Products, Services and Solutions
5.9.4 Beckman Coulter Drug Abuse Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Beckman Coulter Recent Developments
6 North America
6.1 North America Drug Abuse Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug Abuse Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Abuse Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Abuse Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Abuse Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Abuse Testing Market Dynamics
11.1 Drug Abuse Testing Industry Trends
11.2 Drug Abuse Testing Market Drivers
11.3 Drug Abuse Testing Market Challenges
11.4 Drug Abuse Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
